Avid Bioservices Inc (CDMO): Dr. Bruce Freimark [Dir./Pre-Clin.Res.On...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	72
Posts	4827
Boards Moderated	0
Alias Born	01/24/2004

cjgaddy

Re: cjgaddy post# 199584

Wednesday, 12/24/2014 10:19:07 AM

Wednesday, December 24, 2014 10:19:07 AM

Dr. Bruce Freimark [Dir./Pre-Clin.Res.Oncology] speaking 2-9-15 at Keystone Tumor Immunology Conference in Alberta, on how PS-Targeting “enhances the anti-tumor activity of immune checkpoint inhibitors”…

Feb8-13 2015: “Keystone: Tumor Immunology: Multidisciplinary Science Driving Combination Therapy (J7)”, Banff, Alberta, Canada
…joint with the meeting on Antibodies as Drugs: Immunological Scaffolds as Therapeutics (J8)
http://www.keystonesymposia.org/15J7
2-9-15 2:30-4:30pm: Workshop1: ‘Integration of Science through Collaboration - New Models’
Bruce Freimark, Peregrine Pharmaceuticals [Dir./Pre-Clin. Research Oncology]
“Antibody-Mediated Blockade of Phosphatidylserine Enhances the Anti-Tumor Activity of Immune Checkpoint Inhibitors by Affecting Myeloid Derived Suppressor Cells (MDSC) and Lymphocyte Populations in the Tumor Microenvironment”
.
.
= = = = = = = = = = = =KNOWN UPCOMING’s:
Jan15-17: Gastrointestinal Cancers Symposium (ASCO/ASTRO/SSO), SanFran http://tinyurl.com/q5dyruw
…Jan16 12-2pm/poster: Adam C. Yopp/Poster (MD/UTSW/Dallas): Ph.2 Data from Bavi+Sorafenib Liver IST

Jan27-29/Avid: WCBP 19th Symposium on the Interface of Regulatory & Analytical Sciences, WashDC http://www.casss.org/?page=WCBP1500

Jan29-30: GTC’s 7th Immunotherapeutics & Immunomonitoring Conf., SanDiego http://tinyurl.com/lqnb3ou (GTC = Global Technolology Community http://www.gtcbio.com )
…Jan30 2:25-2:50pm, Dr. Bruce Freimark (PPHM’s Dir/PreClin.Res) speaks in session=“Combinatorial Immunotherapies”: "Blockade of PS Enhances the Anti-tumor Activity of Targeted Therapy & Immune Checkpoint Inhibitors by Reducing Immunosuppressive Inflammatory Cells in the Tumor Microenvironment”

Feb8-13: Keystone Tumor Immunology Conf., Banff, Alberta http://www.keystonesymposia.org/15J7
…Feb9 Dr. Bruce Freimark [Dir./Pre-Clin.Res.Oncology], “Antibody-Mediated Blockade of PS Enhances the Anti-Tumor Activity of Immune Checkpoint Inhibitors by Affecting Myeloid Derived Suppressor Cells (MDSC) and Lymphocyte Populations in the Tumor Microenvironment”

~Mar10: FY'15/Q3 (q/e 1-31-15) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm

Mar25-28: Society of Surgical Oncology's 68th Annual Cancer Symposium (SSO 2015), Houston http://tinyurl.com/q667hua
…Mar28 12:45pm/Oral-Pres: Adam C. Yopp (MD/UTSW/Dallas), Ph.2 Data) from Bavi+Sorafenib Liver IST, ”A Phase II Study of Bavituximab & Sorafenib in Advanced Hepatocellular Carcinoma (HCC)”

Mar30-Apr2/Avid/Booth114: IBC's Biopharm. Dev. & Prod. Week, Huntington Beach http://www.ibclifesciences.com/BDPWeek